Benzamidobenzoic acids as potent PqsD inhibitors for the treatment of Pseudomonas aeruginosa infections

• DOI: 10.1016/j.ejmech.2014.02.014
• Publication Date: 2014-02-11T08:16:12Z
• Authors: Stefan Hinsberger; Johannes C. de Jong; Matthias Groh; Jörg Haupenthal; Rolf W. Hartmann
• Keywords: 0301 basic medicine; 03 medical and health sciences; Magnetic Resonance Spectroscopy; Pseudomonas aeruginosa; Pseudomonas Infections; Benzoates; Mass Spectrometry; Anti-Bacterial Agents; 3. Good health

Targeting PqsD is a promising novel approach to disrupt bacterial cell-to-cell-communication in Pseudomonas aeruginosa. In search of selective PqsD inhibitors, two series of benzamidobenzoic acids - one published as RNAP inhibitors and the other as PqsD inhibitors - were investigated for inhibitory activity toward the respective other enzyme. Additionally, novel derivatives were synthesized and biologically evaluated. By this means, the structural features needed for benzamidobenzoic acids to be potent and, most notably, selective PqsD inhibitors were identified. The most interesting compound of this study was the 3-Cl substituted compound 5 which strongly inhibits PqsD (IC₅₀ 6.2 μM) while exhibiting no inhibition of RNAP.